journal article·2018-10-19Open access

The Use of Some Clay Minerals as Natural Resources for Drug Carrier Applications

Marina Massaro, Carmelo Giuseppe Colletti, Giuseppe Lazzara, Serena Riela

Abstract

The goal of modern research is to use environmentally preferable materials. In this context, clay minerals are emerging candidates for their bio- and ecocompatibility, low cost and natural availability. Clay minerals present different morphologies according to their layer arrangements. The use of clay minerals, especially in biomedical applications is known from ancient times and they are regaining attention in recent years. The most representative clay minerals are kaolinit, montmorillonite, sepiolites and halloysite. This review summarizes some clay minerals and their derivatives for application as nanocontainer for biologically active species.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy

Dipartimento di Fisica e Chimica (DiFC), University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy

References (100+)

Show source-provided references
1. Clay Minerals and Their Beneficial Effects Upon Human Health: A Review10.1016/S0169-1317(01)00085-0 ↗
2. Bergaya, F., and Lagaly, G. (2006). General Introduction: Clays, Clay Minerals, and Clay Science. Developments in Clay Science, Elsevier. Chapter 1.10.1016/S1572-4352(05)01001-9 ↗
3. Clay and Non-Clay Minerals in the Pharmaceutical Industry: Part I. Excipients and Medical Applications10.1016/j.clay.2009.07.017 ↗
4. López-Galindo, A., Viseras, C., Aguzzi, C., and Cerezo, P. (2011). Pharmaceutical and Cosmetic Uses of Fibrous Clays. Developments in Clay Science, Elsevier.10.1016/B978-0-444-53607-5.00013-X ↗
5. Carretero, M.I., Gomes, C.S.F., and Tateo, F. (2013). Clays, Drugs, and Human Health. Developments in Clay Science, Elsevier.10.1016/B978-0-08-098259-5.00025-1 ↗
6. Khurana, I.S., Kaur, S., Kaur, H., and Khurana, R.K. (2015). Multifaceted Role of Clay Minerals in Pharmaceuticals. Future Science OA, 1.10.4155/fso.15.6 ↗
7. Surface Geochemistry of the Clay Minerals10.1073/pnas.96.7.3358 ↗
8. Eslinger, E., and Pevear, D.R. (1988). Clay Minerals for Petroleum Geologists and Engineers, SEPM.10.2110/scn.88.22 ↗
9. Changes in the Structure and Porosity of Hollow Spherical Allophane under Alkaline Conditions10.1016/j.clay.2018.09.028 ↗
10. Cytotoxicity of Natural Allophane Nanoparticles on Human Lung Cancer A549 Cells10.1016/j.clay.2016.10.037 ↗
11. New Opportunities for Drug Delivery Carrier of Natural Allophane Nanoparticles on Human Lung Cancer A549 Cells10.1016/j.clay.2017.04.017 ↗
12. Drug–Clay Nanohybrids as Sustained Delivery Systems10.1016/j.clay.2016.01.021 ↗
13. Halloysite Clay Nanotubes for Loading and Sustained Release of Functional Compounds10.1002/adma.201502341 ↗
14. Selective Modification of Halloysite Lumen with Octadecylphosphonic Acid: New Inorganic Tubular Micelle10.1021/ja210258y ↗
15. Pharmaceutical Applications of Some Spanish Clays (Sepiolite, Palygorskite, Bentonite): Some Preformulation Studies10.1016/S0169-1317(98)00050-7 ↗
16. Current Challenges in Clay Minerals for Drug Delivery10.1016/j.clay.2010.01.007 ↗
17. Multiple Renal Silica Calculi10.1136/bmj.1.5846.146 ↗
18. Silica Stones in the Urinary Bladder10.1016/S0140-6736(82)92620-4 ↗
19. Drug-Induced Urinary Calculi
20. Pepsin Hydrolysis of the Adherent Mucus Barrier and Subsequent Gastric Mucosal Damage in the Rat: Effect of Diosmectite and 16,16 Dimethyl Prostaglandin E2
21. Intercalated 2d Nanoclay for Emerging Drug Delivery in Cancer Therapy10.1007/s12274-017-1466-x ↗
22. Emerging Integrated Nanoclay-Facilitated Drug Delivery System for Papillary Thyroid Cancer Therapy10.1038/srep33335 ↗
23. Kaolinite in Pharmaceutics and Biomedicine10.1016/j.ijpharm.2017.09.056 ↗
24. NICE (2018, September 12). Drug Reports (Thr 15670/0020), (Pl 14894/0297), (Pl: 21727/0018-23). Available online: http://www.evidence.nhs.uk/.
25. The Release of a Model Low-Dose Drug (Riboflavine) from Hard Gelatin Capsule Formulations10.1111/j.2042-7158.1979.tb13410.x ↗
26. Formulation of Pyridoxine Hydrochloride Sustained Release Capsules: Effect of Propylene Glycol Co-Solvent on the in Vitro Release10.5897/AJPP2013.3528 ↗
27. The in-Vitro Uptake of a Low Dose Drug (Riboflavine) by Some Adsorbents10.3109/03639048709040190 ↗
28. Stability of Vitamins A, B1, and C in Selected Vehicle Matrices10.1002/jps.2600511115 ↗
29. A Unique Application and Characterization of Eudragit E 30 D Film Coatings in Sustained Release Formulations10.1016/0378-5173(86)90211-5 ↗
30. Effect of Formulation Components on Drug Release from Multiparticulates10.3109/03639049409041974 ↗
31. Evaluation of tablet disintegrants
32. Development of Fast-Disintegrating Pellets in a Rotary Processor10.1081/DDC-120015353 ↗
33. Chitosan–Kaolin Coprecipitate as Disintegrant in Microcrystalline Cellulose-Based Pellets Elaborated by Extrusion–Spheronization10.3109/10837450.2011.653820 ↗
34. Effect of Common Classes of Excipients on Extrusion-Spheronization10.3109/02652049709006817 ↗
35. In Vitro Evaluation of Pellets Containing Enteric Coprecipitates of Nifedipine Formed by Non-Aqueous Spheronization10.1016/0378-5173(95)04370-5 ↗
36. A Comparison of Solute Migration in a Test Granulation Dried by Fluidization and Other Methods10.1111/j.2042-7158.1975.tb09494.x ↗
37. A Study of the Mechanisms of Wet Spherical Agglomeration of Pharmaceutical Powders10.3109/03639049609042001 ↗
38. Current Perspectives of Solubilization: Potential for Improved Bioavailability10.1080/03639040701429333 ↗
39. Evaluation of Acrylic-Based Modified-Release Film Coatings10.1016/0378-5173(87)90031-7 ↗
40. Linearization of Drug Delivery from Sustained-Release Dosage Forms, Synthetic Gel Systems10.3109/03639049609069351 ↗
41. Oil-in-Water Pickering Emulsions Stabilized by Phyllosilicates at High Solid Content10.1016/j.colsurfa.2014.09.037 ↗
42. Synergetic Effect of Reactive Surfactants and Clay Particles on Stabilization of Nonaqueous Oil-in-Oil (O/O) Emulsions10.1080/01932691.2013.769110 ↗
43. The Crystallinity of Several Spanish Kaolins: Correlation with Sodium Amylobarbitone Release
44. Use of Porous Aluminosilicate Pellets for Drug Delivery10.1080/02652040500100196 ↗
45. Polymer Excipients Enable Sustained Drug Release in Low Ph from Mechanically Strong Inorganic Geopolymers10.1016/j.rinphs.2012.02.001 ↗
46. Methoxy-Modified Kaolinite as a Novel Carrier for High-Capacity Loading and Controlled-Release of the Herbicide Amitrole10.1038/srep08870 ↗
47. Experimental Investigation of Virus and Clay Particles Cotransport in Partially Saturated Columns Packed with Glass Beads10.1016/j.jcis.2014.10.066 ↗
48. Structural, Textural and Protein Adsorption Properties of Kaolinite and Surface Modified Kaolinite Adsorbents10.1016/j.clay.2013.12.027 ↗
49. Emerging Nanoclay Composite for Effective Hemostasis10.1002/adfm.201704452 ↗
50. Graphene-Kaolin Composite Sponge for Rapid and Riskless Hemostasis10.1016/j.colsurfb.2018.05.016 ↗
51. Organokaolin for the Uptake of Pharmaceuticals Diclofenac and Chloramphenicol from Water10.1016/j.cej.2017.08.057 ↗
52. Use of Clays as Drug Delivery Systems: Possibilities and Limitations10.1016/j.clay.2006.06.015 ↗
53. Application of Montmorillonite in Bentonite as a Pharmaceutical Excipient in Drug Delivery Systems10.1007/s40005-016-0258-8 ↗
54. Influence of Dispersion Conditions of Two Pharmaceutical Grade Clays on Their Interaction with Some Tetracyclines10.1016/j.clay.2005.03.007 ↗
55. Bello, M.L., Junior, A.M., Vieira, B.A., Dias, L.R.S., de Sousa, V.P., Castro, H.C., Rodrigues, C.R., and Cabral, L.M. (2015). Sodium Montmorillonite/Amine-Containing Drugs Complexes: New Insights on Intercalated Drugs Arrangement into Layered Carrier Material. PLoS ONE, 10.10.1371/journal.pone.0121110 ↗
56. Adsorption of Salicylic Acid on Bentonite and Kaolin and Release Experiments10.1016/j.clay.2006.07.008 ↗
57. Organoclays: Properties, Preparation and Applications10.1016/j.clay.2008.02.006 ↗
58. Montmorillonite as a Drug Carrier: Surface Deposition of Papaverine on the Papaverine-Veegum Complex
59. Gastroretentive Montmorillonite-Tetracycline Nanoclay for the Treatment of Helicobacter Pylori Infection10.1016/j.ijpharm.2015.06.049 ↗
60. Hybrid Materials Based on Montmorillonite and Citostatic Drugs: Preparation and Characterization10.1016/j.clay.2011.01.031 ↗
61. Montmorillonite as a Drug Delivery System: Intercalation and in Vitro Release of Timolol Maleate10.1016/j.ijpharm.2009.03.004 ↗
62. Organo Montmorillonite as Drug Delivery Vehicle for the Extended Release of an Antibiotic Drug
63. Use of Unnatural Amino Acids for Design of Novel Organomodified Clays as Components of Nanocomposite Biomaterials10.1098/rsta.2010.0008 ↗
64. Review of Clay-Drug Hybrid Materials for Biomedical Applications: Administration Routes10.1346/CCMN.2016.0640204 ↗
65. Characterization and Application of Intercalated Montmorillonite with Verapamil and Its Polymethyl Methacrylate Nanocomposite in Drug Delivery10.1080/03602559.2014.909462 ↗
66. Instrumental Characterization of the Smectite Clay–Gentamicin Hybrids10.1007/s12034-015-0943-7 ↗
67. Compositional, Technical and Safety Specifications of Clays to Be Used as Pharmaceutical and Cosmetic Products10.1016/j.clay.2006.06.016 ↗
68. Organo-Modified Bentonite for Gentamicin Topical Application: Interlayer Structure and in Vivo Skin Permeation10.1016/j.clay.2018.03.029 ↗
69. Montmorillonite Nanodevices for the Colon Metronidazole Delivery10.1016/j.ijpharm.2013.09.017 ↗
70. Biopharmaceutical Improvement of Praziquantel by Interaction with Montmorillonite and Sepiolite10.1016/j.clay.2017.12.024 ↗
71. Extended-Release of Chlorpromazine Intercalated into Montmorillonite Clays10.1016/j.micromeso.2018.03.017 ↗
72. Clay-Biosurfactant Materials as Functional Drug Delivery Systems: Slowing Down Effect in the in Vitro Release of Cinnamic Acid10.1016/j.clay.2016.10.039 ↗
73. Anirudhan, T.S., and Parvathy, J. (2018). Novel Thiolated Chitosan–Polyethyleneglycol Blend/Montmorillonite Composite Formulations for the Oral Delivery of Insulin. Bioact. Carbohydr. Diet. Fibre, in press.10.1016/j.bcdf.2018.02.003 ↗
74. Intercalation of Metformin into Montmorillonite10.1039/C7DT04197G ↗
75. Interaction of Curcumin in a Drug Delivery System Including a Composite with Poly(Lactic-Co-Glycolic Acid) and Montmorillonite: A Density Functional Theory and Molecular Dynamics Study10.1039/C7TB01964E ↗
76. Synthesis of Highly Intercalated Urea-Clay Nanocomposite Via Domestic Montmorillonite as Eco-Friendly Slow-Release Fertilizer10.1080/03650340.2016.1177175 ↗
77. Urea–Montmorillonite-Extruded Nanocomposites: A Novel Slow-Release Material10.1021/jf3001229 ↗
78. Controlled Release of Agrochemicals Intercalated into Montmorillonite Interlayer Space10.1155/2014/656287 ↗
79. Nanocomposites of Pla and Pcl Based on Montmorillonite and Sepiolite10.1016/j.msec.2008.11.005 ↗
80. Thermal and Morphological Characterisation of Organically Modified Sepiolite10.1016/j.micromeso.2007.04.020 ↗
81. Adsorption of Pb2+, Cd2+ and Sr2+ Ions onto Natural and Acid-Activated Sepiolites10.1016/j.clay.2006.11.008 ↗
82. Polyimide/Sepiolite Nanocomposite Films: Preparation, Morphology and Properties10.1016/j.materresbull.2011.06.009 ↗
83. Porous Materials as Delivery and Protective Agents for Vitamin A10.1039/C6RA12026A ↗
84. Role of Sepiolite in the Release of Active Compounds from Gelatin–Egg White Films10.1016/j.foodhyd.2011.09.003 ↗
85. The Release of Cefazolin from Chitosan/Polyvinyl Alcohol/Sepiolite Nanocomposite Hydrogel Films10.1007/s13726-016-0480-2 ↗
86. Sepiolite Based Materials for Storage and Slow Release of Nitric Oxide10.1039/c3nj00452j ↗
87. Physical Interactions between DNA and Sepiolite Nanofibers, and Potential Application for DNA Transfer into Mammalian Cells10.1038/srep36341 ↗
88. Cellular Uptake Pathways of Sepiolite Nanofibers and DNA Transfection Improvement10.1038/s41598-017-05839-3 ↗
89. Chemical Modification of Halloysite Nanotubes for Controlled Loading and Release10.1039/C8TB00543E ↗
90. Halloysite Nanotubes as Support for Metal-Based Catalysts10.1039/C7TA02996A ↗
91. Covalently Modified Halloysite Clay Nanotubes: Synthesis, Properties, Biological and Medical Applications10.1039/C7TB00316A ↗
92. Clay Nanotubes for Encapsulation and Sustained Release of Drugs10.1142/S1793292007000441 ↗
93. Thermodynamics of Proton Binding of Halloysite Nanotubes10.1021/acs.jpcc.6b01127 ↗
94. Biomimetic Cell-Mediated Three-Dimensional Assembly of Halloysite Nanotubes10.1039/c2cc38254g ↗
95. Self-Healing Coatings Based on Halloysite Clay Polymer Composites for Protection of Copper Alloys10.1021/am400936m ↗
96. Halloysite Clay Nanotubes as a Ceramic “Skeleton” for Functional Biopolymer Composites with Sustained Drug Release10.1039/c3tb20059k ↗
97. In-Vitro Release Characteristics of Tetracycline Hcl, Khellin and Nicotinamide Adenine Dineculeotide from Halloysite; a Cylindrical Mineral10.1080/02652040010019532 ↗
98. Exploiting the Colloidal Stability and Solubilization Ability of Clay Nanotubes/Ionic Surfactant Hybrid Nanomaterials10.1021/jp307961q ↗
99. Halloysite Nanotube with Fluorinated Lumen: Non-Foaming Nanocontainer for Storage and Controlled Release of Oxygen in Aqueous Media10.1016/j.jcis.2013.11.026 ↗
100. Modified Halloysite Nanotubes: Nanoarchitectures for Enhancing the Capture of Oils from Vapor and Liquid Phases10.1021/am404693r ↗